These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

429 related items for PubMed ID: 15368471

  • 1. Androgen receptor (AR) expression in AR-negative prostate cancer cells results in differential effects of DHT and IGF-I on proliferation and AR activity between localized and metastatic tumors.
    Plymate SR, Tennant MK, Culp SH, Woodke L, Marcelli M, Colman I, Nelson PS, Carroll JM, Roberts CT, Ware JL.
    Prostate; 2004 Nov 01; 61(3):276-90. PubMed ID: 15368471
    [Abstract] [Full Text] [Related]

  • 2. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
    Unni E, Sun S, Nan B, McPhaul MJ, Cheskis B, Mancini MA, Marcelli M.
    Cancer Res; 2004 Oct 01; 64(19):7156-68. PubMed ID: 15466214
    [Abstract] [Full Text] [Related]

  • 3. Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cells.
    Arnold JT, Le H, McFann KK, Blackman MR.
    Am J Physiol Endocrinol Metab; 2005 Mar 01; 288(3):E573-84. PubMed ID: 15536203
    [Abstract] [Full Text] [Related]

  • 4. Androgens induce prostate cancer cell proliferation through mammalian target of rapamycin activation and post-transcriptional increases in cyclin D proteins.
    Xu Y, Chen SY, Ross KN, Balk SP.
    Cancer Res; 2006 Aug 01; 66(15):7783-92. PubMed ID: 16885382
    [Abstract] [Full Text] [Related]

  • 5. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
    Bartucci M, Morelli C, Mauro L, Andò S, Surmacz E.
    Cancer Res; 2001 Sep 15; 61(18):6747-54. PubMed ID: 11559546
    [Abstract] [Full Text] [Related]

  • 6. TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells.
    Zhu ML, Partin JV, Bruckheimer EM, Strup SE, Kyprianou N.
    Prostate; 2008 Feb 15; 68(3):287-95. PubMed ID: 18163430
    [Abstract] [Full Text] [Related]

  • 7. 5alpha-androstane-3alpha,17beta-diol supports human prostate cancer cell survival and proliferation through androgen receptor-independent signaling pathways: implication of androgen-independent prostate cancer progression.
    Yang Q, Titus MA, Fung KM, Lin HK.
    J Cell Biochem; 2008 Aug 01; 104(5):1612-24. PubMed ID: 18320593
    [Abstract] [Full Text] [Related]

  • 8. An AKT activity threshold regulates androgen-dependent and androgen-independent PSA expression in prostate cancer cell lines.
    Paliouras M, Diamandis EP.
    Biol Chem; 2008 Jun 01; 389(6):773-80. PubMed ID: 18627304
    [Abstract] [Full Text] [Related]

  • 9. Effect of zinc on regulation of insulin-like growth factor signaling in human androgen-independent prostate cancer cells.
    Banudevi S, Senthilkumar K, Sharmila G, Arunkumar R, Vijayababu MR, Arunakaran J.
    Clin Chim Acta; 2010 Feb 01; 411(3-4):172-8. PubMed ID: 19913001
    [Abstract] [Full Text] [Related]

  • 10. Androgens activate mitogen-activated protein kinase via epidermal growth factor receptor/insulin-like growth factor 1 receptor in the mouse PC-1 cell line.
    Hamzeh M, Robaire B.
    J Endocrinol; 2011 Apr 01; 209(1):55-64. PubMed ID: 21220406
    [Abstract] [Full Text] [Related]

  • 11. Interaction of IGF signaling and the androgen receptor in prostate cancer progression.
    Wu JD, Haugk K, Woodke L, Nelson P, Coleman I, Plymate SR.
    J Cell Biochem; 2006 Oct 01; 99(2):392-401. PubMed ID: 16639715
    [Abstract] [Full Text] [Related]

  • 12. Insulin-like growth factor I is a comitogen for hepatocyte growth factor in a rat model of hepatocellular carcinoma.
    Price JA, Kovach SJ, Johnson T, Koniaris LG, Cahill PA, Sitzmann JV, McKillop IH.
    Hepatology; 2002 Nov 01; 36(5):1089-97. PubMed ID: 12395318
    [Abstract] [Full Text] [Related]

  • 13. Increased insulin-like growth factor I receptor expression and signaling are components of androgen-independent progression in a lineage-derived prostate cancer progression model.
    Krueckl SL, Sikes RA, Edlund NM, Bell RH, Hurtado-Coll A, Fazli L, Gleave ME, Cox ME.
    Cancer Res; 2004 Dec 01; 64(23):8620-9. PubMed ID: 15574769
    [Abstract] [Full Text] [Related]

  • 14. In vivo progression of LAPC-9 and LNCaP prostate cancer models to androgen independence is associated with increased expression of insulin-like growth factor I (IGF-I) and IGF-I receptor (IGF-IR).
    Nickerson T, Chang F, Lorimer D, Smeekens SP, Sawyers CL, Pollak M.
    Cancer Res; 2001 Aug 15; 61(16):6276-80. PubMed ID: 11507082
    [Abstract] [Full Text] [Related]

  • 15. Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor.
    Culig Z, Hobisch A, Cronauer MV, Radmayr C, Trapman J, Hittmair A, Bartsch G, Klocker H.
    Cancer Res; 1994 Oct 15; 54(20):5474-8. PubMed ID: 7522959
    [Abstract] [Full Text] [Related]

  • 16. Dihydrotestosterone interacts with EGFR/MAPK signalling and modulates EGFR levels in androgen receptor-positive LNCaP prostate cancer cells.
    Mukherjee B, Mayer D.
    Int J Oncol; 2008 Sep 15; 33(3):623-9. PubMed ID: 18695894
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of in vivo breast cancer growth by antisense oligodeoxynucleotides to type I insulin-like growth factor receptor mRNA involves inactivation of ErbBs, PI-3K/Akt and p42/p44 MAPK signaling pathways but not modulation of progesterone receptor activity.
    Salatino M, Schillaci R, Proietti CJ, Carnevale R, Frahm I, Molinolo AA, Iribarren A, Charreau EH, Elizalde PV.
    Oncogene; 2004 Jul 01; 23(30):5161-74. PubMed ID: 15122317
    [Abstract] [Full Text] [Related]

  • 18. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments].
    Dong AQ, Kong MJ, Ma ZY, Qian JF, Fan JQ, Xu XH.
    Zhonghua Yi Xue Za Zhi; 2007 Jun 05; 87(21):1506-9. PubMed ID: 17785094
    [Abstract] [Full Text] [Related]

  • 19. Androgen receptor and TGFbeta1/Smad signaling are mutually inhibitory in prostate cancer.
    van der Poel HG.
    Eur Urol; 2005 Dec 05; 48(6):1051-8. PubMed ID: 16257107
    [Abstract] [Full Text] [Related]

  • 20. Transcriptional regulation of insulin-like growth factor-I receptor gene expression in prostate cancer cells.
    Damon SE, Plymate SR, Carroll JM, Sprenger CC, Dechsukhum C, Ware JL, Roberts CT.
    Endocrinology; 2001 Jan 05; 142(1):21-7. PubMed ID: 11145562
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.